Anlon Healthcare (AHCL)
FAST GROWERFairStock Score: 55/100 — STEADY
Score breakdown: P/E: 1/3 · ROCE: 1/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹143.75 |
| Market Cap | ₹576.8 Cr |
| P/E Ratio | 20.48 |
| ROCE | 24.83% |
| ROE | —% |
| Dividend Yield | 0% |
| Profit Growth | 306.83% |
| Debt/Equity | 0.27 |
| Sales Growth | 280.13% |
| Promoter Holding | 52.68% |
| 52-Week Range | ₹9.08 — ₹143.75 |
| Sector | Pharmaceuticals & Biotechnology |
| Book Value | ₹5.11 |
Anlon Healthcare trades with a P/E ratio of 20.48, ROCE of 24.83%, profit growth of 306.83%, debt-to-equity of 0.27. The FairStock Score of 55/100 suggests mixed fundamentals — some metrics look solid while others need improvement.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer